TargED Biopharmaceuticals
PrivateLast Round
Series A
Extension
Jun 24, 2026
Total Funding Raised
$94.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve the treatment of thrombosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TargED Biopharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
TargED Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 24, 2026 | ||||
| Grant | Jun 30, 2025 | ||||
| Series A | Feb 22, 2022 | ||||
| Seed | Nov 24, 2020 |
Key People
Founding team and executive leadership
TargED Biopharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Fund+ | Series A Extension, Series A |
| Andera Partners | Series A Extension, Series A |
| Inkef Capital | Series A Extension, Series A |
| Hadean Ventures | Series A Extension, Series A |
| BioGeneration Ventures | Series A, Series A Extension |
| Sunstone Life Science Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 615% MoM, from 196 to 1.4K.
- Mar 5, 2026
Rob Dekker joins as the new Vice President CMC.
TargED Biopharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TargED Biopharmaceuticals's valuation, stock price, and market status.